Mark A. Brockman

Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction

Daniel E. Kaufmann, Daniel G. Kavanagh, Florencia Pereyra et al. · Nature Immunology · 2007 · 513 citations

Life Sciences, Immunology, Infectious Diseases +16

Escape from the Dominant HLA-B27-Restricted Cytotoxic T-Lymphocyte Response in Gag Is Associated with a Dramatic Reduction in Human Immunodeficiency Virus Type 1 Replication

Arne Schneidewind, Mark A. Brockman, Ruifeng Yang et al. · Journal of Virology · 2007 · 314 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition

Toshiyuki Miura, Mark A. Brockman, Arne Schneidewind et al. · Journal of Virology · 2008 · 297 citations · Full text

Life Sciences, Genetics, Immunology +17

IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells

Mark A. Brockman, Douglas S. Kwon, Daniel P. Tighe et al. · Blood · 2009 · 285 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Escape and Compensation from Early HLA-B57-Mediated Cytotoxic T-Lymphocyte Pressure on Human Immunodeficiency Virus Type 1 Gag Alter Capsid Interactions with Cyclophilin A

Mark A. Brockman, Arne Schneidewind, Matthew Lahaie et al. · Journal of Virology · 2007 · 261 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17